Vaccine to pathogenic immune activation cells during infections
US10632186B1 · kind B1 · utility
1Cited by
2References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 21, 2019 |
| Grant date | Apr 28, 2020 |
| Priority date | — |
| Expiry date | Mar 21, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/15034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel method for preventing or treating an infectious disease in a subject in need thereof. In particular the method includes the administration of a combination, pharmaceutical combination, medicament or kit-of-parts having a first part including a CD8 vaccine specific for at least one infectious disease-related antigen, a second part including an agent neutralizing circulating alpha interferon and/or an agent blocking interferon alpha signaling, and/or a third part including a type III interferon and/or an agent stimulating the production of type III interferon.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.